NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/04/2026
Back to search
Official data from USPTO
MOSAIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MOSAIQ
ST13
US500000086178459Class
1, 5, 9, 10
Filing
86178459
Registration
4820522
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
08/04/2026
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
01/29/2014
Registration date
09/29/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/04/2026
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
11
Owner location
St Helier, GB
Examiner
SOBRAL, CHRISTINA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
QBD (QS IP) Limited
Representatives
Katrina G. Hull Markery Law LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for scientific or research use provided as part of a kit; test kits consisting of diagnostic preparations for scientific or research use; diagnostic reagents and diagnostic reagents for analyticalscientific and industrial use; diagnostic assay preparationassaysfor scientificindustrial and research purposes
Class 5
Diagnostic reagents derived from blood or in-vitro culture for medical diagnostic purposes; protein based microarrays for medical diagnostic purposes in the nature of antigen typing and antibody identificationblood grouping and disease screening; protein based microarrays for in-vitro testing for medical diagnostic purposes; diagnostic reagents for medical use; chemical reagents for medical diagnosis and analysis; diagnostic assay preparations in the nature of assays and substances in the nature of reagents for blood grouping and disease screening for clinical and medical use; medical diagnostic reagents for testing bloodblood components and plasma for clinical and medical use; medical diagnostic reagents for clinical and medical use as control agents for in vitro diagnostic tests; medical diagnostic reagents for clinical and medical use for virology screening for donor blood; medical diagnostic assays for clinical and medical use for antigen typing and antibody identificationblood grouping and disease screening; diagnostic preparations and kits comprised of medical diagnostic reagents for sensitivity testingquality control and proficiency testing in relation to diagnostic techniquesprocesses and instrumentsall for clinical medical use
Class 9
Scientific research and laboratory apparatus for diagnostic testing in the nature of antigen typing and antibody identificationblood grouping and disease screening; Laboratory equipmentmicroarrays; none of the aforesaid relating to electronic medical records and software for electronic medical records
Class 10
Medical diagnostic testing instruments for blood typing; Medical diagnostic testing instruments for screening blood and blood products; Medical diagnostic testing instruments for antigen typing; Medical diagnostic testing instruments for antibody identificationblood grouping and disease screening; microarrays in the form of medical testing instruments for in-vitro testing
Publications
History of USPTO decisions and trademark events.
51 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/04/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/04/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/03/2026
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
05/29/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/29/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/25/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/29/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/01/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/04/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/04/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/03/2022
E815
TEAS SECTION 8 & 15 RECEIVED
09/29/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/13/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/12/2021
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/12/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/29/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/23/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/23/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/29/2015
PUBO
PUBLISHED FOR OPPOSITION
07/14/2015
NPUB
NOTICE OF PUBLICATION
06/24/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/08/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/22/2015
CNSL
LETTER OF SUSPENSION MAILED
03/03/2015
CNSL
SUSPENSION LETTER WRITTEN
03/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/01/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/01/2015
CNFR
FINAL REFUSAL MAILED
12/02/2014
CNFR
FINAL REFUSAL WRITTEN
12/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/31/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2014
CNRT
NON-FINAL ACTION MAILED
05/05/2014
CNRT
NON-FINAL ACTION WRITTEN
05/05/2014
DOCK
ASSIGNED TO EXAMINER
05/05/2014
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/14/2014
ALIE
ASSIGNED TO LIE
02/12/2014
MPMK
NOTICE OF PSEUDO MARK MAILED
02/11/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2014
ALIE
ASSIGNED TO LIE
02/06/2014
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/05/2014
NWAP
NEW APPLICATION ENTERED
02/01/2014
Continuous trademark protection
Get notified about every new filing that threatens MOSAIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.